Last update 23 Jan 2025

Engelhard Arzneimittel GmbH & Co. KG

Private Company|
1872|
Germany
|
< 10
|
www.engelhard.de

Overview

Tags

Skin and Musculoskeletal Diseases
Mouth and Tooth Diseases
Infectious Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
no Data
No Data
Disease DomainCount
Infectious Diseases1
Top 5 Drug TypeCount
Small molecule drug1

Related

1
Drugs associated with Engelhard Arzneimittel GmbH & Co. KG
Chloramine T
Target-
Mechanism-
Active Org.
Engelhard Arzneimittel GmbH & Co. KG
Originator Org.
Engelhard Arzneimittel GmbH & Co. KG
Active Indication
Herpes Labialis
Inactive Indication-
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
DE
First Approval Date20 Dec 2007
15
Clinical Trials associated with Engelhard Arzneimittel GmbH & Co. KG
CTIS2023-507370-41-00
/ Not yet recruitingPhase 4
Randomized, controlled, open-label, multi-center trial to compare the efficacy and safety of three herbal medicinal products in the treatment of acute bronchitis - EA-20-01-032
NCT04703673
/ CompletedNot Applicable
Non-interventional Study on the Quality of Life Before and After Intake of Sinolpan® (Forte) in Inflammatory Diseases of the Respiratory Tract - an Anonymous Patient Survey
DRKS00020584
/ CompletedNot Applicable
Assessment of wound healing efficacy and local tolerability of a wound gel with intraindividual comparison using an abrasive wound model in a single-center, randomized, investigator-blind clinical investigation - EA-19-02-083
100 Clinical Results associated with Engelhard Arzneimittel GmbH & Co. KG
Login to view more data
0 Patents (Medical) associated with Engelhard Arzneimittel GmbH & Co. KG
Login to view more data
19
Literatures (Medical) associated with Engelhard Arzneimittel GmbH & Co. KG
01 Nov 2023Planta Medica
Ivy leaf dry extract EA 575​ is the first phytotherapeutic drug known to mediate biased β2-receptor signaling
01 Nov 2023Planta Medica
A meta-analysis confirms the efficacy of ivy leaves dry extract EA 575​ as treatment of acute cough in adults
01 Nov 2023Planta Medica
Treatment of rhinosinusitis with 1,8-cineole and nasal spray under real- world conditions: influence on the quality of life
1
News (Medical) associated with Engelhard Arzneimittel GmbH & Co. KG
12 Feb 2013
Lansco Colors Hires New Senior VP of Sales
100 Deals associated with Engelhard Arzneimittel GmbH & Co. KG
Login to view more data
100 Translational Medicine associated with Engelhard Arzneimittel GmbH & Co. KG
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 03 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Chloramine T
Herpes Labialis
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free